Reconstruction of the Carotid Bifurcation in Patients With Arterial Hypertension of 2-3 Degrees

StatusCompleted
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial completed
    • Eligibility criteria expanded, about 9 words
    • Study description expanded, about 4 words
  2. Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 112 to confirmed 90
    • Study completion date: Sep 1, 2025 to Sep 1, 2026
    • Site details revised
    v3
  3. Primary completion date: Sep 1, 2023 to Sep 1, 2024v2
  4. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Carotid endarterectomy (CEA) is a well-established procedure for preventing ischemic brain damage. Stenosis of the precerebral vessels are often combined with arterial hypertension. In recent decades, many works have appeared that indicate that the course of arterial hypertension (AH) changes after CEA. However, it remains unknown how this is related to the choice of surgical tactics.
Trial Details
NCT Number NCT05931003
Lead Sponsor Samara State Medical University
Conditions
(from sponsor)		 Hypertension, Carotid Stenosis, Symptomatic Carotid Artery Stenosis
Related terms Carotid Stenosis, Hypertension
Enrollment 90 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov